Dachaigh › Aillse a' bhroilleach › California › Mountain View
Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Mountain View, CA
Tha 26 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Mountain View (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A’ fastadhÌre 3
- Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
A Study of PHST001 in Advanced Solid Tumors
A’ fastadhÌre 1
- Stanford University School of Medicine, Palo Alto · 5 mìle air falbh
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A’ fastadhÌre 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
A’ fastadhÌre 1/2
- Stanford Medicine Cancer Center, Stanford · 5 mìle air falbh
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A’ fastadhÌre 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
A’ fastadhÌre 1
- Stanford University Medical Center, Stanford · 5 mìle air falbh
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- Stanford University Medical Center, Stanford · 5 mìle air falbh
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A’ fastadhÌre 3
- Stanford Cancer Center, Palo Alto · 5 mìle air falbh
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A’ fastadhÌre 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A’ fastadhÌre 3
- Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
A’ fastadhÌre 1
- Stanford University Hospital, Stanford · 5 mìle air falbh
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
A’ fastadhÌre 3
- Research Site, Palo Alto · 5 mìle air falbh
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
A’ fastadhÌre 2
- Stanford Cancer Institute, Palo Alto · 5 mìle air falbh
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A’ fastadhÌre 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mìle air falbh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A’ fastadhÌre 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mìle air falbh
- agus 1 a bharrachd
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
A’ fastadhÌre 2
- Stanford University, Stanford · 5 mìle air falbh
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A’ fastadhÌre 2/3
- Local Institution - 0358, Stanford · 5 mìle air falbh
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A’ fastadhÌre 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
A’ fastadhÌre 1
- Stanford University Medical Center, Palo Alto · 5 mìle air falbh
Magnetic Resonance Imaging of Breast Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Stanford University School of Medicine, Stanford · 5 mìle air falbh
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
A’ fastadhSgrùdadh amharc
- Stanford University School of Medicine, Stanford · 5 mìle air falbh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
A’ fastadhÌre 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mìle air falbh
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mìle air falbh
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
A’ fastadhÌre 1
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
A’ fastadh
- Stanford University, Stanford · 5 mìle air falbh
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A’ fastadhSgrùdadh amharc
- Stanford Cancer Institute, Palo Alto · 5 mìle air falbh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Stanford · 5 mìle air falbh
Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile
- New York City, NY136 sgrùdaidhean
- Houston, TX126 sgrùdaidhean
- Boston, MA112 sgrùdaidhean
- Nashville, TN81 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Edison, NJ68 sgrùdaidhean
- St. Louis, MO64 sgrùdaidhean
- Queens, NY64 sgrùdaidhean
- Durham, NC64 sgrùdaidhean
- Chicago, IL59 sgrùdaidhean
- Philadelphia, PA56 sgrùdaidhean
- Dallas, TX55 sgrùdaidhean
Sgrùdaidhean eile ann an Mountain View
- Aillse (gach seòrsa)40 sgrùdaidhean
- Ailse metastatach25 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag21 sgrùdaidhean
- Leukemia myeloid geur19 sgrùdaidhean
- Cancer Ovarian19 sgrùdaidhean
- Galar Speactram Autism17 sgrùdaidhean
- Ailseachadh nan Sgamhan17 sgrùdaidhean
- Aillse Prostata15 sgrùdaidhean
- Fàilligeadh a' Chridhe15 sgrùdaidhean
- Autism13 sgrùdaidhean
- Leukemia lymphoblastic geur13 sgrùdaidhean
- Aillse colorectal13 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.